• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSS1900062 注射用重组人凝血因子IX -Fc融合蛋白 eftrenonacog alfa Lyophilized Biological Products Import Drug Application 2019-11-27 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2019-12-14 view
JXSS1900063 注射用重组人凝血因子IX -Fc融合蛋白 eftrenonacog alfa Lyophilized Biological Products Import Drug Application 2019-11-27 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2019-12-14 view
JXSS1900064 注射用重组人凝血因子IX -Fc融合蛋白 eftrenonacog alfa Lyophilized Biological Products Import Drug Application 2019-11-27 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2019-12-14 view
JXSS1900065 注射用重组人凝血因子IX -Fc融合蛋白 eftrenonacog alfa Lyophilized Biological Products Import Drug Application 2019-11-27 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2019-12-14 view